Net profit of RPG Life Sciences rose 8.67% to Rs 7.52 crore in the quarter ended March 2022 as against Rs 6.92 crore during the previous quarter ended March 2021. Sales rose 11.90% to Rs 103.80 crore in the quarter ended March 2022 as against Rs 92.76 crore during the previous quarter ended March 2021.
For the full year,net profit rose 28.70% to Rs 51.48 crore in the year ended March 2022 as against Rs 40.00 crore during the previous year ended March 2021. Sales rose 13.11% to Rs 440.16 crore in the year ended March 2022 as against Rs 389.14 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 103.80 | 92.76 | 12 | 440.16 | 389.14 | 13 |
OPM % | 13.02 | 13.65 | – | 19.62 | 17.97 | – |
PBDT | 14.71 | 12.87 | 14 | 88.83 | 70.05 | 27 |
PBT | 10.93 | 8.95 | 22 | 73.17 | 53.58 | 37 |
NP | 7.52 | 6.92 | 9 | 51.48 | 40.00 | 29 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.